Merck: Merck won FDA approval for the first cholesterol pill to rival powerful injectables
Lipfendra, a once-daily pill, reduced LDL cholesterol by up to 59% in late-stage trials, rivaling existing injectable treatments
Read full article »
Merck is a New Jersey-based multinational biopharmaceutical company that develops and commercializes novel therapeutics and vaccines for the treatment of a range of diseases.
Read more